The Latest Cardiac and Vascular News
BOSTON, May 8, 2018 /PRNewswire/ — Thousands of clinicians, scientists, researchers and innovators from around the world will gather together Wednesday, May 9 through Saturday, May 12 at the Boston Convention and Exhibition Center for Heart Rhythm 2018, the Heart Rhythm Society’s (HRS) 39th Annual Scientific Sessions, to explore recent developments in the field of cardiac pacing […]
CARLSBAD, Calif., May 8, 2018 /PRNewswire/ — Acutus Medical®, a global heart rhythm technology company, today announced that the AcQMap® High Resolution Imaging and Mapping System has been utilized for the first time in U.S. patients. The company also revealed initiation of a new clinical study to evaluate the technology during atrial fibrillation retreatment […]
SANTA CLARA, Calif.–(BUSINESS WIRE)–Cardiva Medical, Inc., an innovator in the field of vascular closure, today announced the completion of the AMBULATE pivotal trial, one of several clinical trials in the company’s AMBULATE series that are studying the VASCADE MVP Venous Vascular Closure System for use in the closure of mid-bore […]
WATERTOWN, Mass., May 7, 2018 /PRNewswire/ — Affera, Inc, a private medical device company focused on innovative cardiac arrhythmia treatment solutions, announced today its integrated platform will be highlighted in eight scientific sessions at the Heart Rhythm Society 2018 (HRS) meeting in Boston, Massachusetts. Affera’s revolutionary lesion formation technology offers a solution designed to optimize procedural efficiency […]
SEATTLE, May 7, 2018 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, including the Carnation Ambulatory Monitor (“CAM™”), the world’s only P-wave centric™ ambulatory cardiac monitor and arrhythmia detection device, announced today that the American Heart Journal has published the results of a head-to-head […]
IRVINE, Calif., May 2, 2018 /PRNewswire/ — Johnson & Johnson Medical Devices Companies* announced today that Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of heart arrhythmias, has enrolled and treated the first patient in its QDOT AF Study.** The study will evaluate the delivery of high power, short duration ablation […]
MARLBOROUGH, Mass., May 7, 2018 /PRNewswire/ — CardioFocus, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted approval for the HeartLight Excalibur Balloon, a next-generation technology designed for the treatment of paroxysmal atrial fibrillation (PAF)*. The Excalibur Balloon leverages the proven universal balloon design of the company’s FDA-approved HeartLight® Endoscopic Ablation System and introduces an […]
Southwest Texas South Lake – ( BUSINESS WIRE ) – ( BUSINESS WIRE ) – As a US-based medical equipment company, continuous wavelet transform (CWT) signal processing method and field of electrocardiogram inspection through application of artificial intelligence to lead the innovation in the heart Sciences today announced that it has welcomed Peter · W · McFarlane […]
KIRKLAND, Wash.–(BUSINESS WIRE)–Cardiac Insight, Inc., a leading U.S. developer of wearable cardiac medical devices and diagnostic software systems with proprietary algorithms, announced today the company will showcase its innovative solutions for the first time at Heart Rhythm Society’s 39th Annual Scientific Sessions. Heart Rhythm 2018 will be held May 9-11, 2018 […]
ABBOTT PARK, Ill., May 3, 2018 /PRNewswire/ — Abbott (NYSE: ABT) today announced U.S. Food and Drug Administration (FDA) clearance of the Advisor™ HD Grid Mapping Catheter, Sensor Enabled™. Advisor HD Grid employs a new design that allows physicians to see things differently, capturing and analyzing data in a novel manner to create […]
